The rhytidectomy market size has grown strongly in recent years. It will grow from $2.75 billion in 2024 to $2.93 billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to surgeon expertise and training, accessibility and affordability, marketing and media influence, economic conditions, improvements in safety and efficacy.
The rhytidectomy market size is expected to see strong growth in the next few years. It will grow to $3.97 billion in 2029 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to consumer confidence and spending, social media influence, health and wellness trends, medico-legal developments, rise in beauty consciousness. Major trends in the forecast period include celebrity endorsements and public figures, rising demand among younger demographics, cultural perception of aging, increased awareness and education, demand for natural-looking results.
The rising demand for cosmetic procedures is anticipated to drive growth in the rhytidectomy market. Cosmetic surgery encompasses both surgical and nonsurgical procedures aimed at reshaping and enhancing body structures to improve appearance and boost confidence. Rhytidectomy, commonly known as a facelift, is a specific type of cosmetic surgery designed to address visible signs of aging on the neck and face. As the demand for cosmetic procedures continues to grow, so too will the need for rhytidectomy. For example, in September 2023, the International Society of Aesthetic Plastic Surgery, a US-based organization, reported that in 2022, plastic surgeons performed over 14.9 million surgical procedures and 18.8 million nonsurgical procedures worldwide, marking an overall increase of 11.2%. Consequently, the increasing demand for cosmetic procedures is expected to positively impact the rhytidectomy market.
The growth of the rhytidectomy market is expected to be propelled by the increasing geriatric population. Older adults, constituting the geriatric segment (aged 65 and above), are turning to rhytidectomy procedures to address the visible signs of aging, thereby enhancing self-esteem and overall quality of life. As of October 2022, the World Health Organization highlighted a global trend where 1 in 6 individuals would be aged 60 or older by 2030, reaching an estimated 2.1 billion elderly people by 2050. The population of individuals aged 80 years or older is projected to triple from 2020 to 2050, reaching approximately 426 million people. This demographic shift toward an aging population is a significant factor driving the growth trajectory of the rhytidectomy market.
The rhytidectomy market is experiencing a notable trend driven by technological advancements, with companies actively incorporating cutting-edge technologies to maintain their market positions. A case in point is BTL Aesthetics, a UK-based medical equipment company, which introduced Emface in January 2023. This innovative non-invasive facial treatment utilizes high-intensity focused electromagnetic (HIFEM) technology to stimulate and tone facial muscles. By inducing powerful muscle contractions, Emface aims to reduce wrinkles, fine lines, and sagging skin, resulting in improved muscle definition and skin elasticity. This exemplifies the industry's commitment to leveraging advanced technologies for enhanced cosmetic solutions.
Strategic partnerships are a prominent strategy among major players in the rhytidectomy industry, serving to broaden market presence, drive technological advancements, and offer comprehensive facial rejuvenation solutions. L'Oréal Group, a France-based cosmetics company, exemplifies this approach through its collaboration with Verily Life Sciences LLC, a US-based health tech company. By combining L'Oréal's skin expertise with Verily's clinical capabilities, the partnership explores the intricate connections between exposome, skin aging, and deep skin biology. This collaboration integrates technologies such as sensors and artificial intelligence (AI) to develop innovative dermatology solutions and potentially introduce new services.
In February 2023, Athenix, a US-based medical practice specializing in plastic surgery, acquired Marina Plastic Surgery and MedSpa for an undisclosed amount. This acquisition aims to strengthen Athenix's position in the plastic surgery industry, particularly in rhytidectomy procedures. Marina Plastic Surgery and MedSpa, a US-based provider of plastic surgery services, aligns with Athenix's expansion goals and enhances its service offerings. This strategic approach exemplifies the industry's focus on growth and diversification through targeted acquisitions.
Major companies operating in the rhytidectomy market include Johnson & Johnson, AbbVie Inc., Cutera Inc., Galderma S.A., Revance Therapeutics Inc., Sientra Inc., Bausch Health Companies Inc., Sinclair Pharma PLC, Mentor Worldwide LLC, Cynosure LLC, Merz Pharmaceuticals GmbH, Lumenis Ltd., Apyx Medical Corporation, Anika Therapeutics Inc., InMode Ltd., Sciton Inc., Alma Lasers Ltd., Syneron Medical Ltd., Evolus Inc., Ipsen Pharma, Teoxane Laboratories, Medytox Inc., Ulthera Inc., Venus Concept Ltd., Candela Corporation, ThermiGen LLC, Endo Aesthetics LLC, Fotona d.o.o., Aesthetics Biomedical Inc.
North America was the largest region in the rhytidectomy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global rhytidectomy market report during the forecast period. The regions covered in the rhytidectomy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the rhytidectomy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Rhytidectomy, commonly known as a facelift, is a surgical procedure designed to address visible signs of aging by eliminating excess facial skin, tightening underlying muscles, and repositioning tissues for a more youthful and revitalized appearance. This comprehensive procedure targets concerns such as sagging skin, deep folds, jowls, and loose neck skin, resulting in a smoother, firmer, and lifted facial contour.
Various types of rhytidectomy cater to different needs, including the traditional facelift, superficial musculoaponeurotic system (SMAS) facelift, deep plane facelift, mid facelift, mini facelift, and cutaneous facelift. The traditional facelift involves incisions around the hairline and behind the ears to lift and tighten underlying muscles and tissues in the face and neck region. Rhytidectomy procedures are sought by individuals across different age groups, ranging from 30-39 years to 70 years and above. These treatments address various areas such as the mandible, chin, nose, jaw, injectable, and malar. Hospitals, clinics, and other healthcare providers offer these services to meet the diverse needs of individuals seeking facial rejuvenation.
The rhytidectomy market research report is one of a series of new reports that provides rhytidectomy market statistics, including rhytidectomy industry global market size, regional shares, competitors with a rhytidectomy market share, detailed rhytidectomy market segments, market trends and opportunities, and any further data you may need to thrive in the rhytidectomy industry. This rhytidectomy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The rhytidectomy market includes revenues earned by entities by providing rhytidectomy surgery services, including liquid facelifts, s-lifts, and temporary or brow lifts. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The rhytidectomy market size is expected to see strong growth in the next few years. It will grow to $3.97 billion in 2029 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to consumer confidence and spending, social media influence, health and wellness trends, medico-legal developments, rise in beauty consciousness. Major trends in the forecast period include celebrity endorsements and public figures, rising demand among younger demographics, cultural perception of aging, increased awareness and education, demand for natural-looking results.
The rising demand for cosmetic procedures is anticipated to drive growth in the rhytidectomy market. Cosmetic surgery encompasses both surgical and nonsurgical procedures aimed at reshaping and enhancing body structures to improve appearance and boost confidence. Rhytidectomy, commonly known as a facelift, is a specific type of cosmetic surgery designed to address visible signs of aging on the neck and face. As the demand for cosmetic procedures continues to grow, so too will the need for rhytidectomy. For example, in September 2023, the International Society of Aesthetic Plastic Surgery, a US-based organization, reported that in 2022, plastic surgeons performed over 14.9 million surgical procedures and 18.8 million nonsurgical procedures worldwide, marking an overall increase of 11.2%. Consequently, the increasing demand for cosmetic procedures is expected to positively impact the rhytidectomy market.
The growth of the rhytidectomy market is expected to be propelled by the increasing geriatric population. Older adults, constituting the geriatric segment (aged 65 and above), are turning to rhytidectomy procedures to address the visible signs of aging, thereby enhancing self-esteem and overall quality of life. As of October 2022, the World Health Organization highlighted a global trend where 1 in 6 individuals would be aged 60 or older by 2030, reaching an estimated 2.1 billion elderly people by 2050. The population of individuals aged 80 years or older is projected to triple from 2020 to 2050, reaching approximately 426 million people. This demographic shift toward an aging population is a significant factor driving the growth trajectory of the rhytidectomy market.
The rhytidectomy market is experiencing a notable trend driven by technological advancements, with companies actively incorporating cutting-edge technologies to maintain their market positions. A case in point is BTL Aesthetics, a UK-based medical equipment company, which introduced Emface in January 2023. This innovative non-invasive facial treatment utilizes high-intensity focused electromagnetic (HIFEM) technology to stimulate and tone facial muscles. By inducing powerful muscle contractions, Emface aims to reduce wrinkles, fine lines, and sagging skin, resulting in improved muscle definition and skin elasticity. This exemplifies the industry's commitment to leveraging advanced technologies for enhanced cosmetic solutions.
Strategic partnerships are a prominent strategy among major players in the rhytidectomy industry, serving to broaden market presence, drive technological advancements, and offer comprehensive facial rejuvenation solutions. L'Oréal Group, a France-based cosmetics company, exemplifies this approach through its collaboration with Verily Life Sciences LLC, a US-based health tech company. By combining L'Oréal's skin expertise with Verily's clinical capabilities, the partnership explores the intricate connections between exposome, skin aging, and deep skin biology. This collaboration integrates technologies such as sensors and artificial intelligence (AI) to develop innovative dermatology solutions and potentially introduce new services.
In February 2023, Athenix, a US-based medical practice specializing in plastic surgery, acquired Marina Plastic Surgery and MedSpa for an undisclosed amount. This acquisition aims to strengthen Athenix's position in the plastic surgery industry, particularly in rhytidectomy procedures. Marina Plastic Surgery and MedSpa, a US-based provider of plastic surgery services, aligns with Athenix's expansion goals and enhances its service offerings. This strategic approach exemplifies the industry's focus on growth and diversification through targeted acquisitions.
Major companies operating in the rhytidectomy market include Johnson & Johnson, AbbVie Inc., Cutera Inc., Galderma S.A., Revance Therapeutics Inc., Sientra Inc., Bausch Health Companies Inc., Sinclair Pharma PLC, Mentor Worldwide LLC, Cynosure LLC, Merz Pharmaceuticals GmbH, Lumenis Ltd., Apyx Medical Corporation, Anika Therapeutics Inc., InMode Ltd., Sciton Inc., Alma Lasers Ltd., Syneron Medical Ltd., Evolus Inc., Ipsen Pharma, Teoxane Laboratories, Medytox Inc., Ulthera Inc., Venus Concept Ltd., Candela Corporation, ThermiGen LLC, Endo Aesthetics LLC, Fotona d.o.o., Aesthetics Biomedical Inc.
North America was the largest region in the rhytidectomy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global rhytidectomy market report during the forecast period. The regions covered in the rhytidectomy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the rhytidectomy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Rhytidectomy, commonly known as a facelift, is a surgical procedure designed to address visible signs of aging by eliminating excess facial skin, tightening underlying muscles, and repositioning tissues for a more youthful and revitalized appearance. This comprehensive procedure targets concerns such as sagging skin, deep folds, jowls, and loose neck skin, resulting in a smoother, firmer, and lifted facial contour.
Various types of rhytidectomy cater to different needs, including the traditional facelift, superficial musculoaponeurotic system (SMAS) facelift, deep plane facelift, mid facelift, mini facelift, and cutaneous facelift. The traditional facelift involves incisions around the hairline and behind the ears to lift and tighten underlying muscles and tissues in the face and neck region. Rhytidectomy procedures are sought by individuals across different age groups, ranging from 30-39 years to 70 years and above. These treatments address various areas such as the mandible, chin, nose, jaw, injectable, and malar. Hospitals, clinics, and other healthcare providers offer these services to meet the diverse needs of individuals seeking facial rejuvenation.
The rhytidectomy market research report is one of a series of new reports that provides rhytidectomy market statistics, including rhytidectomy industry global market size, regional shares, competitors with a rhytidectomy market share, detailed rhytidectomy market segments, market trends and opportunities, and any further data you may need to thrive in the rhytidectomy industry. This rhytidectomy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The rhytidectomy market includes revenues earned by entities by providing rhytidectomy surgery services, including liquid facelifts, s-lifts, and temporary or brow lifts. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Rhytidectomy Market Characteristics3. Rhytidectomy Market Trends and Strategies4. Rhytidectomy Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid and Recovery on the Market32. Global Rhytidectomy Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the Rhytidectomy Market34. Recent Developments in the Rhytidectomy Market
5. Global Rhytidectomy Growth Analysis and Strategic Analysis Framework
6. Rhytidectomy Market Segmentation
70 Years and Above
7. Rhytidectomy Market Regional and Country Analysis
8. Asia-Pacific Rhytidectomy Market
9. China Rhytidectomy Market
10. India Rhytidectomy Market
11. Japan Rhytidectomy Market
12. Australia Rhytidectomy Market
13. Indonesia Rhytidectomy Market
14. South Korea Rhytidectomy Market
15. Western Europe Rhytidectomy Market
16. UK Rhytidectomy Market
17. Germany Rhytidectomy Market
18. France Rhytidectomy Market
19. Italy Rhytidectomy Market
20. Spain Rhytidectomy Market
21. Eastern Europe Rhytidectomy Market
22. Russia Rhytidectomy Market
23. North America Rhytidectomy Market
24. USA Rhytidectomy Market
25. Canada Rhytidectomy Market
26. South America Rhytidectomy Market
27. Brazil Rhytidectomy Market
28. Middle East Rhytidectomy Market
29. Africa Rhytidectomy Market
30. Rhytidectomy Market Competitive Landscape and Company Profiles
31. Rhytidectomy Market Other Major and Innovative Companies
35. Rhytidectomy Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Rhytidectomy Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on rhytidectomy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for rhytidectomy? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The rhytidectomy market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Type: Traditional Facelift; Superficial Musculoaponeurotic System (SMAS) Facelift; Deep Plane Facelift; Mid Facelift; Mini Facelift; Cutaneous Facelift2) By Age: 30-39 Years; 40-54 Years; 55-69 Years; 70 Years and Above
3) By Area of Treatment: Mandibular; Chin; Nasal; Jaw; Injectable; Malar
4) By End User: Hospitals; Clinics; Other End Users
Subsegments:
1) By Traditional Facelift: Full Facelift; Lower Facelift2) By Superficial Musculoaponeurotic System (SMAS) Facelift: SMAS Plication Facelift; SMAS Flap Facelift
3) By Deep Plane Facelift: Extended Deep Plane Facelift; Short-Scar Deep Plane Facelift
4) By Mid Facelift: Endoscopic Mid Facelift; Open Mid Facelift
5) By Mini Facelift: Mini Facelift with Local Anesthesia; Mini Facelift With Sedation
6) By Cutaneous Facelift: Full Cutaneous Facelift; Limited Cutaneous Facelift
Key Companies Mentioned: Johnson & Johnson; AbbVie Inc.; Cutera Inc.; Galderma S.A.; Revance Therapeutics Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
- Johnson & Johnson
- AbbVie Inc.
- Cutera Inc.
- Galderma S.A.
- Revance Therapeutics Inc.
- Sientra Inc.
- Bausch Health Companies Inc.
- Sinclair Pharma PLC
- Mentor Worldwide LLC
- Cynosure LLC
- Merz Pharmaceuticals GmbH
- Lumenis Ltd.
- Apyx Medical Corporation
- Anika Therapeutics Inc.
- InMode Ltd.
- Sciton Inc.
- Alma Lasers Ltd.
- Syneron Medical Ltd.
- Evolus Inc.
- Ipsen Pharma
- Teoxane Laboratories
- Medytox Inc.
- Ulthera Inc.
- Venus Concept Ltd.
- Candela Corporation
- ThermiGen LLC
- Endo Aesthetics LLC
- Fotona d.o.o.
- Aesthetics Biomedical Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | February 2025 |
| Forecast Period | 2025 - 2029 |
| Estimated Market Value ( USD | $ 2.93 Billion |
| Forecasted Market Value ( USD | $ 3.97 Billion |
| Compound Annual Growth Rate | 7.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 29 |
